跳至主要内容
临床试验/EUCTR2005-002475-32-DE
EUCTR2005-002475-32-DE进行中(未招募)不适用

Pilotstudy about endocrinilogical, peripherphysilogical and painreducing effects of Gamma-hydroxybutyrate in combination with operant-behaviour-therapeutic paintherapy with patients in Fibromyalgia-Syndrome - GHB and OVT with patients in Fibromyalgia (FMS)

Charitè Universitätmeditin Berlin0 个研究点开始时间: 2006年5月16日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • ACR-criteria of Fibromalgia-Syndrome
  • containment of german language
  • motivation of therapy
  • written acceptance of the patient
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • psychiatric-diseased person
  • taking sedated drugs (including opiate)
  • desire of pension
  • persons under 18 and over 80 years
  • persons, who are unable to consent
  • instable arterial hypertension
  • seriously interference of renal function
  • alcoholintoxication
  • taking opiate

研究者

发起方
Charitè Universitätmeditin Berlin

相似试验